Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung

Lung Cancer

Volumn 32, Issue 3, 2001, Pages 265-279

  Malkinson, Alvin M ^a  

^a UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ARTICLE; CANCER PREVENTION; CANCER RESEARCH; CANCER THERAPY; LUNG ADENOCARCINOMA; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOPREVENTION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DNA, NEOPLASM; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MICE; TRANSPLANTATION, HETEROLOGOUS;

EID: 0034997385     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00232-4     Document Type: Article

References (105)

1. Landis S.H., Murray T., Bolden S., Wingo P.A. Cancer statistics. CA. Cancer J. Clin. 49:1999;8-31.
2. Schottenfeld D. Epidemiology of the lung. Pass H.I., Mitchell J.B., Johnson D.H., Turrisi A.T. Lung Cancer: Principles and Practice. 1996;305-323 Lippincott-Raven Press, Philadelphia, PA.
3. Barsky S.H., Cameron R., Osann K.E., Tomita D., Holmes E.C. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer. 73:1994;1163-1179.
4. Shimkin M.B. Contrary to Nature. 1979;US Government Printing Office, Washington, DC.
5. Carmichael J., Smyth J.F. Chemotherapy studies in human non-small cell lung cancer xenografts transplanted in immune-deprived mice. Winograd B., Peckham M.J., Pinedo H.M. Human Tumour Xenografts in Anticancer Drug Development. 1988;51-56 Springer, New York.
6. Uriel J.L. Fetal characteristics of cancer. Becker F.F. Cancer: a Comprehensive Treatise. 3:1975;21-56 Plenum, New York.
7. Shoemaker R.H., McLemore T.L., Abbott B.J., et al. Winograd B., Peckham M.J., Pinedo H.M. Human Tumour Xenografts in Anticancer Drug Development. 1988;115-122 Springer, New York.
8. Khleif S.N., Curt G.A. Animal models in drug development. Holland J.F., Bast R.C. Jr, Morton D.L., Frei E., Kufe D.W., Weichselbaum R.R. 4th edn Cancer Medicine. 1:1997;855-868 Williams & Wilkins, Baltimore, MD.
9. McLemore T.L., Eggleston J.C., Shoemaker R.H., et al. Comparison of intrapulmonary, percutaneous intrathoracic and subcutaneous models for the propagation of human pulmonary and nonpulmonary cancer cell lines in athymic nude mice. Cancer Res. 48:1988;2880-2886.
10. INK4aβ in mouse lung tumor cells. Oncogene. 13:1996;1885-1891.
11. Fidler I.J., Gersten D.M., Rigg C.W. Day S.B., Myers W.P.L., Stansly P., Garattini S., Lewis M.G. Cancer Invasion and Metastasis Biologic Mechanisms and Therapy. 1977;277-280 Raven Press, New York.
12. Layton M.G., Franks L.M. Heterogeneity in a spontaneous mouse lung carcinoma: selection and characterization of stable metastatic variants. Brit. J. Cancer. 49:1984;415-421.
13. Schrump D.S., Chen A., Consoli U. Inhibition of lung cancer proliferation by antisense cyclin D. Cancer Gene. Ther. 3:1996;131-135.
14. Chaudhuri R.K., Sigler E., Dupont E., Trosko J.E., Malkinson A.M., Ruch R.J. Gap junctional intercellular communication in mouse lung epithelial cell lines: effects of cell transformation and tumor promoters. Cancer Lett. 71:1993;11-18.
15. Ruch R.J., Cesen-Cummings K., Malkinson A.M. Role of gap junctions in lung neoplasia. Exp. Lung Res. 24:1998;523-540.
16. Shimkin M.B., Stoner G.D. Lung tumors in mice: application in carcinogenesis bioassay. Adv. Cancer Res. 21:1975;1-56.
17. Malkinson A.M. The genetic basis of susceptibility to lung tumors in mice. Toxicology. 54:1989;241-271.
18. Witschi H., Williamson D., Lock S. Enhancement of urethan tumorigenesis in mouse lung by butylated hydroxytoluene. J. Natl. Cancer Inst. 58:1977;301-305.
19. You M., Wang Y., Stoner G., et al. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc. Natl. Acad. Sci. USA. 89:1992;5804-5808.
20. Malkinson A.M., Koski K.M., Evans W.A., Festing M.F.W. Exposure to butylated hydroxytoluene is necessary for lung tumor development in BALB mice treated with low doses of 3-methylcholanthrene. Cancer Res. 57:1997;2832-2834.
21. Guan X., Hardenbrook J., Fernstrom M.J., Chaudhuri R., Malkinson A.M., Ruch R.J. Downregulation by butylated hydroxytoluene of the number and function of gap junctions in epithelial cell lines derived from mouse lung and rat liver. Carcinogenesis. 16:1995;2575-2582.
22. Dwyer-Nield L.D., Thompson J.A., Peljak G., et al. Selective induction of apoptosis in mouse and human lung epithelial cell lines by the tert- butyl hydroxylated metabolite of butylated hydroxytoluene: a proposed role in tumor promotion. Toxicology. 130:1998;115-127.
23. Miller A.C.K., Dwyer L.D., Auerbach C.E., Miley F.B., Dinsdale D., Malkinson A.M. Strain-related differences in the pneumotoxic effects of chronically-administered butylated hydroxytoluene on protein kinase C and calpain. Toxicology. 90:1994;141-159.
24. Rapp U.R., Todaro G.J. Generation of oncogenic mouse type C viruses: in vitro selection of carcinoma-inducing variants. Proc. Natl. Acad. Sci. USA. 77:1980;624-628.
25. Holland M.J., Palmarini M., Garcia-Goti M., Gonzalez L., de las Heras M., Sharp J.M. Jaagsiekte retrovirus establishes a pantropic infection of lymphoid cells of sheep with naturally and experimentally acquired pulmonary adenomatosis. J. Virol. 73:1999;4004-4008.
26. Whitsett J.A., Gerard C. Transgenic mice for study of pulmonary disease. Crystal R.G., West J.B., Weibel E.R., Barnes P.J. The Lung. 1:1997;383-394 Lippincott-Raven Press, Philadelphia, PA.
27. Shimkin M.B., Sasaki T., McDonough M., Baserga R., Thatcher D., Weider R. Relation of thymidine index to pulmonary tumor response in mice receiving urethan and other carcinogens. Cancer Res. 29:1969;994-998.
28. Foley J.F., Anderson M.W., Stoner G.D., Gaul B.W., Hardisty J.F., Maronpot R.R. Proliferative lesions of the mouse lung: progression studies in strain A mice. Exp. Lung Res. 24:1991;157-168.
29. Shimkin M.B., Polissar M.J. Some quantitative observations on the induction and growth of primary pulmonary tumors in strain A mice receiving urethane. J. Natl. Cancer Inst. 16:1955;75-97.
30. Malkinson A.M. Primary lung tumors in mice: an experimentally manipulable model of human adenocarcinoma. Cancer Res. 52:1992;2670s-2676s.
31. Heston W.E. Genetic analysis of susceptibility to induced pulmonary tumors in mice. J. Natl. Cancer Inst. 3:1942;69-78.
32. Rice J.M. The biological behavior of transplacentally induced tumors in mice. Tomatis L., Mohr U. Transplacental Carcinogenesis. 1973;14-22 IARC Scientific, Lyon.
33. Maronpot R.R., Palmiter R.D., Brinster R.L., Sandgren E.P. Pulmonary carcinogenesis in transgenic mice. Exp. Lung Res. 24:1991;305-322.
34. Manenti G., Gariboldi M., Fiorino A., Zanesi N.L., Pierottti M.A., Dragani T.A. Genetic mapping of lung cancer modifier loci specifically affecting tumor initiation and progression. Cancer Res. 57:1997;4164-4166.
35. Thaete L.G., Nesbitt M.N., Malkinson A.M. Lung tumor structure among inbred strains of mice: the pulmonary adenoma hisologic type (Pah) genes. Cancer Lett. 61:1991;15-20.
36. Thaete L.G., Gunning W.T., Stoner G.D., Malkinson A.M. Cellular derivation of lung tumors in sensitive and resistant strains of mice: results at twenty-eight and fifty-six weeks after urethan treatment. J. Natl. Cancer Inst. 78:1987;7434-7439.
37. Branstetter D.G., Stoner G.D., Budd C., Conran P.B., Goldblatt P.J. Effect of gestational development on lung tumor size and morphology in the mouse. Cancer Res. 48:1988;379-386.
38. Malkinson A.M. Genetic studies on lung tumor susceptibility and histogenesis in mice. Environ. Hlth. Perspect. 93:1991;149-159.
39. Mason R.J., Kalina M., Malkinson A.M., Shannon J.M. SP-C expression in urethane induced murine pulmonary tumors. Am. J. Pathol. 156:2000;175-182.
40. Thaete L.G., Malkinson A.M. Differential staining of normal and neoplastic mouse lung epithelia by succinate dehydrogenase histochemistry. Cancer Lett. 52:1990;219-227.
41. Gunning W.T., Stoner G.S., Goldblatt P.J. Glyceraldehyde-3-phosphate dehydrogenase and other enzymatic activity in normal mouse lung and in lung tumors. Exp. Lung Res. 17:1991;255-262.
42. Linnoila I. Topography of preneoplasia: morphology and markers. Kane M.A., Bunn P.A. Biology of Lung Cancer. 1998;503-528 Marcel Dekker, New York.
43. Wikenheiser K.A., Clark J.C., Linnoila L., Stahlman M.T., Whitsett J.A. Simian virus 40 large T antigen directed by transcriptional elements of the human surfactant protein C gene produces pulmonary adenocarcinomas in transgenic mice. Cancer Res. 52:1992;5342-5352.
44. Mabry M., Nelkin B.S., Baylin S.B. Evolutionary model of lung cancer. Pass H.I., Mitchell J.B., Johnson D.H., Turrisi A.T. Lung Cancer: Principles and Practice. 1996;133-142 Lippincott-Raven Press, Philadelphia, PA.
45. Siegfried J., Hong Han Y., DeMichele M.A.A. Production of gastrin-releasing peptide by a non-small cell lung carcinoma cell line adapted to serum free conditions. J. Biol. Chem. 269:1994;8596-8603.
46. Sunday M.E., Sikorsky K., Zhang F., Hatzis D. Calcitionin driven v-Ha-ras induces pulmonary neuroendocrine (NE) and non-NE neoplasms. Lab. Invest. 78:1998;166A.
47. Lechner JF, Fugaro JM,. Ras and erbb2. In: Pass HI, Mitchell JB, Johnson DH, Turrisi AT, Minna JD, editors. Lung Cancer: Principles and Practice. 2nd edn., Philadelphia, PA: Lippincott Willliams & Wilkins, 2000:89-97.
48. Li E.E., Heflich H., Bucci T.J., Manjanatha M.G., Blaydes B.S., Delclos K.B. Relationships of DNA adduct formation, K-ras activating mutations and tumorigenic activities of 6-nitrochrysene and its metabolites in the lungs of CD-1 mice. Carcinogenesis. 15:1994;1377-1385.
49. Gressani K.M., Leone-Kabler S., O'Sullivan G., Case L.D., Malkinson A.M., Miller M.S. Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methlycholanthrene and postnatally exposed to butylated hydroxytoluene. Carcinogenesis. 20:1999;2159-2165.
50. Chen B., Liu L., Castonguay A., Maronpot R.R., Anderson M.W., You M. Dose-dependent ras mutation spectra in N-nitrosodiethylamine induced mouse liver tumors and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced mouse lung tumors. Carcinogenesis. 14:1993;1603-1608.
51. Lin L., Festing M.F.W., Devereux T.R., Crist K.A., Christiansen S.C., Wang Y., et al. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp. Lung Res. 24:1998;481-498.
52. Nuzum E.O., Malkinson A.M., Beer D.G. Specific K-ras codon 61 mutations may determine the development of mouse lung adenomas or adenocarcinomas. Molec. Carcinogen. 3:1990;287-295.
53. Siegfried J.M., Gillespie A.T., Mera R., et al. Prognostic value of specific KRAS mutations in lung adenocarcinomas. Cancer Epidemiol. Biomark. Prev. 6:1997;841-847.
54. Belinsky S.A., Nikula K.J., Baylin S.B., Issa J.P.J. Increased cytosine DNA-methyltransferase activity is target cell-specific and an early event in lung cancer. Proc. Natl. Acad. Sci. USA. 93:1996;4045-4050.
55. Malkinson A.M. Molecular changes during the development of pulmonary adenocarcinomas in mouse and man: a comparison. Exp. Lung Res. 24:1998;541-546.
56. Horio Y.L., Schrump D.S., Chen A., Rice P., Malkinson A.M., Roth J.A. K-ras and p53 mutations are early and late events, respectively, in urethane-induced pulmonary carcinogenesis in A/J mice. Molec. Carcinogen. 16:1996;217-223.
57. Sargent LM, Senft JR, Lowry DT, et al. Specific chromosomal changes in mouse lung adenocarcinoma cell lines detected by spectral karyotyping. Proc Am Assoc Cancer Res In press.
58. Rice P.L., Porter S.E., Koski K.M., et al. Reduced receptor expression for platelet-derived growth factor and epidermal growth factor in dividing mouse lung epithelial cells. Molec. Carcinogen. 25:1999;285-294.
59. Malkinson A.M., Siegel D., Forrest G.L., et al. Elevated DT-diaphorase activity and mRNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin C. Cancer Res. 52:1992;4752-4757.
60. Thaete L.G., Siegel D., Malkinson A.M., Ross D. NAD(P)H: quinone oxidoreductase (DT-diaphorase) activities in normal and neoplastic mouse lung epithelia. Int. J. Cancer. 49:1991;145-149.
61. Malkinson A.M., Beer D.S. A single gene in BALB/cBy mice with a major effect on susceptibility to urethane-induced pulmonary adenoma. J. Natl. Cancer Inst. 70:1983;981-986.
62. Malkinson A.M. Inheritance of pulmonary adenoma susceptibility in mice. Prog. Exp. Tumor. Res. 35:1999;78-94.
63. You M., Wang Y., Stoner G., et al. Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids. Proc. Natl. Acad. Sci. USA. 89:1992;5804-5808.
64. Ryan J., Barker P.E., Nesbitt M.N., Ruddle F.H. KRAS2 as a genetic marker for lung tumor susceptibility in inbred mice. J. Natl. Cancer Inst. 79:1985;1351-1357.
65. Gariboldi M., Manenti G., Canzian F., et al. A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nature Genet. 3:1993;132-136.
66. Malkinson A.M., You M. The intronic structure of cancer-related genes regulates susceptibility to cancer. Molec. Carcinogen. 10:1994;61-65.
67. Chen B., Johanson L., Wiest J.S., Anderson M.W., You M. Allele-specific activation and expression of the K-ras gene in hybrid mouse lung tumors induced by chemical carcinogens. Proc. Natl. Acad. Sci. USA. 91:1994;1589-1593.
68. Herzog C.R., Noh S., Lantry L.E., Guan K.-L., You M. Cdkn2a encodes functional variation of p16INK4a but not p19ARF, which confers selection in mouse lung tumorigenesis. Molec. Carcinogen. 25:1999;92-98.
69. Walley A.J., Cookson W.O.C.M. Genetics of asthma. Stockley R.A. Molecular Biology of the Lung (Asthma and Cancer). 2:1999;23-39 Basel, Birkhauser.
70. Wu A.H., Fontham E.T., Reynold P., et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am. J. Epidemiol. 141:1995;1023-1032.
71. Manenti G., De Gregorio L., Pilotti S., et al. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis. 18:1997;1917-1920.
72. Dragani T.A., Hirohashi S., Juji T., et al. Population-based mapping of pulmonary adenoma susceptibility 1 locus. Cancer Res. 60:2000;5017-5020.
73. Sporn M.B., Dunlop N.M., Newton D.L., Smith J.M. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc. 35:1976;1332-1338.
74. Greenwald P., Kelloff G.J. The role of chemoprevention in cancer control. Stewart B.W., McGregor D., Kleihues P. Principles of Chemoprevention. 1996;13-22 IARC Scientific, Lyon.
75. Wattenberg L.W. Chemoprevention of cancer. Cancer Res. 45:1985;1-8.
76. Kelloff G.J., Boone C.W., Steele V.E., et al. Mechanistic considerations in the evaluation of chemopreventive data. Stewart B.W., McGregor D., Kleihues P. Principles of Chemoprevention. 1996;203-220 IARC Scientific, Lyon.
77. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med, 1994;330:1029-1035.
78. Benner S.E., Lippman S.M., Hong W.K. Chemoprevention strategies for lung and upper aerodigestive tract cancer. Cancer Res. 52:1992;2757s-2763s.
79. Katiyar S.K., Mukhtar H. Tea antioxidants in cancer chemoprevention, , J. Cell. Biochem. 27:((Suppl)):1997;59-67.
80. Wang Z.Y., Hong J.Y., Huang M.-T., Reuhl K.R., Conney A.H., Yang C.S. Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res. 52:1992;1943-1947.
81. Lee I.P., Kim Y.H., Kang M.H., Roberts C., Shim J.S., Roh J.K. Chemopreventive effect of green tea (Camellia sinensis) against cigarette smoke-induced mutations (SCE) in humans. J. Cell. Biochem. 27:(Suppl):1997;68-75.
82. Hecht S.S. Approaches to chemoprevention of lung cancer based on carcinogens in tobacco smoke. Environ. Hlth. Perspect. 105:(Suppl 4):1997;955-964.
83. Chung F.-L., Jiao D., Conaway C.C., Smith T.J., Yang C.S., Yu M.C. Chemopreventive potential of thiol conjugates of isothiocyanates for lung cancer and a urinary biomarker of dietary isothiocyanates, , J. Cell. Biochem. 27:(Suppl):1997;76-85.
84. London S.J., Yuan J.-M., Chung F.-L., et al. Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China. Lancet. 356:2000;724-729.
85. Ballard P.L., Hawgood S., Liley H., et al. Regulation of pulmonary surfactant apoprotein SP 28-36 gene in fetal human lung. Proc. Natl. Acad. Sci. USA. 83:1986;9527-9531.
86. Oomen L.C.J.M., Valk M.A., Hart A.A., Demant P. Glucocorticoid hormone effect on transplacental carcinogenesis and lung differentiation: influence of histocompatibility-2 (H-2) complex. J. Natl. Cancer Inst. 81:1989;512-517.
87. Droms K.A., Fernandez C.A., Thaete L.G., Malkinson A.M. Effects of adrenalectomy and corticosterone administration on mouse lung tumor susceptibility and histogenesis. J. Natl. Cancer Inst. 80:1988;365-369.
88. Wattenberg L.W., Wiedmann T.S., Estensen R.D., Zimmerman C.L., Steele V.E., Kelloff G.J. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res. 57:1997;5489-5492.
89. Duperron C., Castonguay A. Chemopreventive efficacies of aspirin and sulindac against lung tumorigenesis in A/J mice. Carcinogenesis. 18:1997;1001-1006.
90. Piazza G.A., Kulchak-Rahm A.L., Krutzch M. Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis. Cancer Res. 55:1995;3110-3116.
91. Malkinson A.M., Koski K.M., Dwyer-Nield L.D., et al. Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone). Carcinogenesis. 19:1998;1353-1356.
92. Soriano A.F., Helfrich B., Chan D.C., Heasley L.E., Bunn P.A., Chou T.-C. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res. 59:1999;6178-6184.
93. Bonomi P. Non-small cell lung cancer chemotherapy. Pass H.I., Mitchell J.B., Johnson D.H., Turrisi A. Lung Cancer: Principles and Practice. 1996;811-824 Lippincott-Raven Press, Philadelphia, PA.
94. Kepa J.K., Ross D. DT-diaphorase activity in NSCLC and SCLC cell lines: a role for fos/jun regulation. Brit. J. Cancer. 79:1999;1679-1684.
95. Winski S.L., Hargreaves R.H.J., Butler J., Ross D. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent. Clin. Cancer Res. 4:1998;3083-3088.
96. Belinsky S.A., Stefanski S.A., Anderson M.W. The A/J mouse lung as a model for developing new chemointervention strategies. Cancer Res. 53:1993;410-416.
97. Zhang Z., Liu Q., Lantry L.E., et al. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin. Cancer Res. 60:2000;901-907.
98. Keith R.L., Miller Y.E., Malkinson A.M., Moore M.D., Geraci M.W. Selective pulmonary prostacylin synthase overexpression in transgenic mice is chemoprotective against lung tumorigenesis. Am. J. Resp. Crit. Care. Med. 159:1999;A206.
99. Mann S.C., Andrews P.A., Howell S.B. Modulation of cis-diamine-dichloroplatinum (II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methlylxanthine in sensitive and resistant human ovarian carcinoma cells. Int. J. Cancer. 48:1991;866.
100. Lange-Carter C.A., Fossli T., Jahnsen T., Malkinson A.M. Decreased expression of the type I isozyme of cAMP-dependent protein kinase in tumor cell lines of lung epithelial origin. J. Biol. Chem. 265:1990;7814-7818.
101. Porter SE, Dwyer-nield LD, Malkinson AM. Regulation of lung epithelial cell morphology by cAMP-dependent protein kinase type I isozyme (PKA I), Am J Physiol: Lung Cell Mol Physiol, in press.
102. Cesen-Cummings K., Fernstrom M.J., Malkinson A.M., Ruch R.J. Frequent reduction of gap junctional intercellular communication and connexin 43 expression in human and mouse lung carcinoma cells. Carcinogenesis. 19:1998;61-68.
103. Ruch RJ, Porter S, Koffler LD, Dwyer-nield LD, Malkinson AM. Defective gap junctional intercellular communication in lung cancer: loss of an important mediator of tissue homeostasis and phenotypic regulation. Exp Lung Res, in press.
104. Malkinson A.M., Bauer A., Meyer A., et al. Experimental evidence from an animal model of adenocarcinoma that chronic inflammation enhances lung cancer risk. Chest. 117:2000;S228.
105. Williams C.S., Tsujii M., Reese J., Dey S.K., Dubois R.N. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Invest. 105:2000;1589-1594.